Biograbbit SRL
The score of Biograbbit shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biograbbit's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
Biograbbit's financial analysis
- Solvency67.6%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biograbbit
Biograbbit's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1009.728.131
- VAT number
- BE1009728131
- Peppol
- Registered · 0208:1009728131 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 May 2024
- Registered office
- 9200 Dendermonde
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Biograbbit (SRL) has been based in Dendermonde since 2024, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 18,137 € and equity of 41,593 €; its revenue is not published. Its solvency stands at 67.6%, above the median of its sector (60.4%).
Companies similar to Biograbbit
Companies in the same business, of comparable size and area, outside its group.
- Shift Happens Research and experimental development on natural sciences and engineering Ghent · balance sheet 62,809 €
- FoxBioPath Research and experimental development on natural sciences and engineering Duffel · balance sheet 103,842 €
- ComPro Pharma Research and experimental development on natural sciences and engineering Sprimont · balance sheet 76,879 €
- 1991 Southern Sky Research and experimental development on natural sciences and engineering Anderlecht · balance sheet 77,620 €
- " Akontio " Research and experimental development on natural sciences and engineering Huy · balance sheet 69,650 €
- Consultbio Research and experimental development on natural sciences and engineering Rumst · balance sheet 106,674 €
- Biokey Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 2,606 €
- Greenewable Consulting & Management Research and experimental development on natural sciences and engineering Seraing · balance sheet 61,907 €
Frequently asked questions about Biograbbit
What is the revenue of Biograbbit?
Biograbbit files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biograbbit?
In Belgium, the VAT number is the company number prefixed with BE: BE1009728131 for Biograbbit, if the company is VAT-registered. Its company number (CBE) is 1009.728.131.
Where is the registered office of Biograbbit?
According to the CBE register, the registered office of Biograbbit is in 9200 Dendermonde.
What is the equity of Biograbbit?
At the close of the 2025 financial year, the equity of Biograbbit amounts to 41,593 €, a solvency of 67.6% of total assets.
Who manages Biograbbit?
The register lists 1 active mandates at Biograbbit. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biograbbit
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →